Effects of metformin added to insulin in adolescents with type 1 diabetes: a crossover randomised controlled trial

被引：0
|
作者：
Yang, D. [1 ]
Xu, W. [1 ]
Zhang, W. [1 ]
Deng, H. [1 ]
Hong, M. [1 ]
Yan, J. [1 ]
Yao, B. [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
880
引用
收藏
页码：S429 / S429
页数：1
相关论文
共 50 条
  • [21] Metformin lowers HbA1c and insulin dose in adolescents with poorly controlled type 1 diabetes
    Hamilton, J
    Zdravkovic, V
    Cummings, E
    Finegood, D
    Daneman, D
    DIABETES, 2002, 51 : A427 - A427
  • [22] Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial
    Snaith, Jennifer R.
    Samocha-Bonet, Dorit
    Evans, Jennifer
    Liu, Zhixin
    Kowalski, Greg
    Bruce, Clinton
    Holmes-Walker, Deborah J.
    Greenfield, Jerry R.
    DIABETIC MEDICINE, 2021, 38 (09)
  • [23] Comparison of metformin and insulin therapy for the treatment of gestational diabetes mellitus-a randomised controlled trial
    Dasari, Papa
    Gundagurti, Bhagyashree
    Karthikeyan, Kayathri
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (04) : 523 - 528
  • [24] Impact of canagliflozin added-on to insulin and metformin in type 2 diabetes: a substudy of the CANVAS trial
    Matthews, D.
    Rosenstock, J.
    Desai, M.
    Capuano, G.
    Meininger, G.
    Canovatchel, W.
    DIABETOLOGIA, 2015, 58 : S357 - S357
  • [25] Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes
    Mads V. Svart
    Nikolaj Rittig
    Ulla Kampmann
    Thomas S. Voss
    Niels Møller
    Niels Jessen
    Diabetologia, 2017, 60 : 1197 - 1206
  • [26] Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes
    Svart, Mads V.
    Rittig, Nikolaj
    Kampmann, Ulla
    Voss, Thomas S.
    Moller, Niels
    Jessen, Niels
    DIABETOLOGIA, 2017, 60 (07) : 1197 - 1206
  • [27] Treatment with liraglutide as adjunct to insulin in type 1 diabetes; effects on counter regulatory response to hypoglycaemia: a randomised, double blind, crossover trial
    Pieber, T. R.
    Deller, S.
    Brunner, M.
    Jensen, L.
    Christiansen, E.
    Kiyomi, F.
    Heller, S. R.
    DIABETOLOGIA, 2013, 56 : S404 - S405
  • [28] Efficacy and safety of liraglutide added to capped insulin treatment in type 1 diabetes, the ADJUNCT TWO™ randomised trial
    Hirsch, I. B.
    Ahren, B.
    Pieber, T.
    Mathieu, C.
    Gomez-Peralta, F.
    Hansen, T.
    Philotheou, A.
    Christiansen, E.
    Jensen, T. J.
    Birch, S.
    Buse, J.
    DIABETOLOGIA, 2016, 59 : S357 - S357
  • [29] Metformin and insulin in type 1 Diabetes
    Meyer, L
    Guerci, B
    DIABETES CARE, 2003, 26 (05) : 1655 - 1656
  • [30] Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
    Petrie, John R.
    Chaturvedi, Nishi
    Ford, Ian
    Brouwers, Martijn C. G. J.
    Greenlaw, Nicola
    Tillin, Therese
    Hramiak, Irene
    Hughes, Alun D.
    Jenkins, Alicia J.
    Klein, Barbara E. K.
    Klein, Ronald
    Ooi, Teik C.
    Rossing, Peter
    Stehouwer, Coen D. A.
    Sattar, Naveed
    Colhoun, Helen M.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08): : 597 - 609
12345